Wall Street brokerages expect Inspire Medical Systems (NASDAQ:INSP) to announce earnings of ($0.36) per share for the current quarter, Zacks reports. Two analysts have made estimates for Inspire Medical Systems’ earnings. The highest EPS estimate is ($0.33) and the lowest is ($0.37). The business is scheduled to report its next quarterly earnings report on Tuesday, November 6th.

According to Zacks, analysts expect that Inspire Medical Systems will report full year earnings of ($4.08) per share for the current year, with EPS estimates ranging from ($6.18) to ($1.98). For the next financial year, analysts forecast that the company will post earnings of ($1.33) per share, with EPS estimates ranging from ($1.39) to ($1.28). Zacks’ earnings per share averages are an average based on a survey of sell-side analysts that cover Inspire Medical Systems.

Inspire Medical Systems (NASDAQ:INSP) last posted its quarterly earnings data on Tuesday, August 7th. The company reported ($0.43) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.51) by $0.08. The firm had revenue of $10.94 million for the quarter, compared to analyst estimates of $9.30 million.

Several equities research analysts have recently weighed in on the stock. Zacks Investment Research upgraded shares of Inspire Medical Systems from a “hold” rating to a “buy” rating and set a $48.00 price objective for the company in a research report on Wednesday, August 1st. Stifel Nicolaus started coverage on shares of Inspire Medical Systems in a report on Tuesday, May 29th. They issued a “buy” rating and a $42.00 price target for the company. Bank of America started coverage on shares of Inspire Medical Systems in a report on Tuesday, May 29th. They issued a “neutral” rating and a $36.00 price target for the company. Wells Fargo & Co started coverage on shares of Inspire Medical Systems in a report on Tuesday, May 29th. They issued an “outperform” rating and a $38.00 price target for the company. Finally, Goldman Sachs Group started coverage on shares of Inspire Medical Systems in a report on Tuesday, May 29th. They issued a “neutral” rating and a $25.00 price target for the company. Three equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus target price of $38.17.

A number of large investors have recently bought and sold shares of INSP. Orbimed Advisors LLC acquired a new stake in Inspire Medical Systems in the second quarter worth $87,161,000. Millennium Management LLC acquired a new stake in Inspire Medical Systems in the second quarter worth $26,752,000. BlackRock Inc. acquired a new stake in Inspire Medical Systems in the second quarter worth $19,624,000. FMR LLC acquired a new stake in Inspire Medical Systems in the second quarter worth $11,340,000. Finally, Federated Investors Inc. PA bought a new position in shares of Inspire Medical Systems in the second quarter valued at $10,949,000.

Shares of INSP traded down $2.91 during trading hours on Monday, hitting $48.22. 115,300 shares of the stock were exchanged, compared to its average volume of 197,553. Inspire Medical Systems has a fifty-two week low of $22.50 and a fifty-two week high of $57.87.

About Inspire Medical Systems

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

Featured Story: Diversification in Your Portfolio

Get a free copy of the Zacks research report on Inspire Medical Systems (INSP)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.